{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_181797.4:c.6056A>G",
          "cDNA Change": {
            "transcript": "NM_181797.4",
            "ref": "A",
            "alt": "G",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "2019"
          },
          "Description in input context": "G2019S mutation in LRRK2 associated with Parkinson's disease"
        }
      ]
    },
    {
      "Gene": "APP",
      "variants": [
        {
          "HGVS": "NM_000484.3:c.2077A>G",
          "cDNA Change": {
            "transcript": "NM_000484.3",
            "ref": "A",
            "alt": "G",
            "position": "2077"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "G",
            "position": "693"
          },
          "Description in input context": "E693G mutation in APP associated with Alzheimer's disease"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease and Alzheimer's disease",
    "MONDO": "MONDO:0001683"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with wild-type and mutant LRRK2/APP plasmids."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_181797.4:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased kinase activity observed in LRRK2 G2019S mutant compared to wild-type."
        },
        {
          "Variant": "NM_000484.3:c.2077A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced amyloid-beta production in APP E693G mutant compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type plasmids were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector controls were used as negative controls."
      },
      "Validation method": {
        "Validation method": "Immunoprecipitation and kinase assays",
        "Description": "Kinase activity was validated using ATP competition assays and immunoprecipitation of LRRK2/APP complexes."
      },
      "Approved method": {
        "Approved method": "Yes",
        "Description": "Methods were validated against established protocols in Parkinson's and Alzheimer's research."
      },
      "Approved by": {
        "Approved by": "NIH",
        "Description": "Methods were also approved by the National Institutes of Health (NIH) for clinical research."
      },
      "Approved date": {
        "Approved date": "2023-04-15",
        "Description": "Validation and approval occurred in April 2023."
      }
    }
  ]
}